Detalhe da pesquisa
1.
Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivo.
Mol Carcinog
; 53(9): 722-35, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23475695